Story perspectives

New FDA Director's Appointment Sparks Controversy and Uncertainty

12/8/2025

46 8

Summary

Story summary

Dr. Tracy Beth Høeg has been appointed acting director of the FDA's Center for Drug Evaluation and Research.
She has previously advocated for stricter COVID-19 vaccine guidelines and questioned the U.S. childhood vaccination schedule.
Critics say her leadership could politicize the FDA and prompt companies to seek regulatory approval overseas.
Her appointment follows a series of abrupt leadership changes within the agency, fueling uncertainty about its direction.

1 of 1

Story summary

Dr. Tracy Beth Høeg has been appointed acting director of the FDA's Center for Drug Evaluation and Research.
She has previously advocated for stricter COVID-19 vaccine guidelines and questioned the U.S. childhood vaccination schedule.
Critics say her leadership could politicize the FDA and prompt companies to seek regulatory approval overseas.
Her appointment follows a series of abrupt leadership changes within the agency, fueling uncertainty about its direction.